Apollo Medical Holdings - רווח נקי למניה (EPS TTM) ASTH

Astrana Health, Inc. (ASTH) is aggressively acquiring private clinics, prioritizing expansion over organic growth. The US domestic market minimizes external risks, although medication inflation from Asia impacts costs. The annual growth of basic net income per share (ttm) visualizes these processes, where the mark 464.50 records this indicator. However, aggressive pressure from insurance behemoths creates serious threats to the business's final margins.

This indicator measures the dynamics of net income per share over a rolling year, allowing for the identification of hidden business degradation or the confirmation of fundamental revenue stability. By analyzing the EPS YoY growth rate (trailing 12 months), investors assess the asset's reliability, which for Astrana Health, Inc. (ASTH) is confirmed by stable free cash flow and an absence of liquidity risks due to its subscription model.